This article presents a regulatory model that would regulate agricultural biotechnology on the basis of the product created and, then, on a tiered risk-based analysis. The article presents this model because United States regulatory agencies are currently reviewing their agricultural...

Some academic writers and public officials assert that intellectual property rights in plants and animals have impeded agricultural biotechnology in developing nations. This article discusses and refutes this claim. What holds back agricultural biotechnology in developing nations is...

The battle over immigration reform is a recent manifestation of a long debate over the relationship between the United States and other countries. To economists, these issues are easy. Since at least the work of David Ricardo (1772-1823), economists have known that international trade is...

Opponents of biotechnology often complain that the large biotech firms have vigorously fought efforts to regulate the industry. In fact, the large firms - Monsanto (now Pfizer), Ciba-Geigy (now Syngenta), DuPont, Pioneer, Dow, Bayer, BASF, et al. - have been anything but consistent opponents of...